| Literature DB >> 35361935 |
Victoria Cotero1, John Graf1, Hiromi Miwa2, Zall Hirschstein3, Khaled Qanud4, Tomás S Huerta4, Ningwen Tai5, Yuyan Ding5, Kevin Jimenez-Cowell5,6, Jacquelyn N Tomaio4, Weiguo Song4, Alex Devarajan4, Tea Tsaava4, Radhika Madhavan1, Kirk Wallace1, Evelina Loghin1, Christine Morton1, Ying Fan1, Tzu-Jen Kao1, Kainat Akhtar3, Meghana Damaraju3, Linda Barenboim3, Teresa Maietta3, Jeffrey Ashe1, Kevin J Tracey4, Thomas R Coleman4, Dino Di Carlo2, Damian Shin3, Stavros Zanos4, Sangeeta S Chavan4, Raimund I Herzog5, Chris Puleo7.
Abstract
Peripheral neurons that sense glucose relay signals of glucose availability to integrative clusters of neurons in the brain. However, the roles of such signalling pathways in the maintenance of glucose homoeostasis and their contribution to disease are unknown. Here we show that the selective activation of the nerve plexus of the hepatic portal system via peripheral focused ultrasound stimulation (pFUS) improves glucose homoeostasis in mice and rats with insulin-resistant diabetes and in swine subject to hyperinsulinemic-euglycaemic clamps. pFUS modulated the activity of sensory projections to the hypothalamus, altered the concentrations of metabolism-regulating neurotransmitters, and enhanced glucose tolerance and utilization in the three species, whereas physical transection or chemical blocking of the liver-brain nerve pathway abolished the effect of pFUS on glucose tolerance. Longitudinal multi-omic profiling of metabolic tissues from the treated animals confirmed pFUS-induced modifications of key metabolic functions in liver, pancreas, muscle, adipose, kidney and intestinal tissues. Non-invasive ultrasound activation of afferent autonomic nerves may represent a non-pharmacologic therapy for the restoration of glucose homoeostasis in type-2 diabetes and other metabolic diseases.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35361935 DOI: 10.1038/s41551-022-00870-w
Source DB: PubMed Journal: Nat Biomed Eng ISSN: 2157-846X Impact factor: 29.234